MktsMarkets

Kura Oncology, Inc.
NASDAQ: KURAKey statistics
KURA News
Stories mentioning KURA from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 18,265 | 17,336 | 20,750 | 15,288 | 14,108 | |||
| Cost of Goods Sold | 262.00 | |||||||
| Gross Profit | 18,003 | 0.00 | 0.00 | |||||
| Operating Expenses | ||||||||
| Research & Development | 65,263 | 64,408 | 67,908 | 62,785 | 55,973 | 52,267 | 41,705 | 39,727 |
| Sales General & Admin | 31,555 | 22,835 | ||||||
| Total Operating Expenses | 103,604 | 100,747 | 87,954 | 78,808 | 76,338 | 59,884 | 56,404 | |
| Operating Income (Loss) | (78,815) | (86,268) | (79,997) | (72,666) | (64,700) | (22,455) | (59,884) | (56,404) |
| Interest Income | ||||||||
| Interest Expense | 406.00 | |||||||
| Other Expense | ||||||||
| Pretax Income | (73,325) | (80,928) | (74,116) | (66,122) | (57,203) | (17,199) | (54,404) | (50,837) |
| Tax Provision | 8.00 | 226.00 | ||||||
| Net Income (Loss) | (73,333) | (80,999) | (74,116) | (66,122) | (57,429) | (19,217) | (54,404) | (50,837) |
| Earnings Per Share (Basic) | (0.83) | (0.92) | (0.85) | (0.75) | (0.66) | (0.22) | (0.63) | (0.59) |
| Earnings Per Share (Diluted) | (0.83) | (0.92) | (0.85) | (0.75) | (0.66) | (0.22) | (0.63) | (0.59) |
| Weighted Average Shares Outstanding (Basic) | 88,610 | 87,676 | 87,645 | 87,586 | 87,415 | 86,161 | 86,950 | 86,635 |
| Weighted Average Shares Outstanding (Diluted) | 88,610 | 87,676 | 87,645 | 87,586 | 87,415 | 86,161 | 86,950 | 86,635 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About KURA
Kura Oncology, Inc. (NASDAQ: KURA) is a stock listed on the Nasdaq Stock Market under the ticker symbol KURA. It last traded at $7.34 (Nov 18, 2026, 4:00 PM ET), down 2.0% on the day. That gives Kura Oncology a market capitalisation of $694.7M.
Over the past 52 weeks KURA has traded between $6.75 and $13.90.
Revenue for the quarter ended Mar 31, 2026 was $18.3M; a net loss of $73.3M. Revenue was up 29.5% from $14.1M in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $18.3M | -$73.3M | -401.5% |
| Dec 31, 2025 | $17.3M | -$81.0M | -467.2% |
| Sep 30, 2025 | $20.8M | -$74.1M | -357.2% |
| Jun 30, 2025 | $15.3M | -$66.1M | -432.5% |
From Kura Oncology’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…